Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Preferred Dividend Payments (2023)

CG Oncology filings provide 1 years of Preferred Dividend Payments readings, the most recent being $18.4 million for Q4 2023.

  • On a quarterly basis, Preferred Dividend Payments changed N/A to $18.4 million in Q4 2023 year-over-year; TTM through Dec 2024 was $18.4 million, a 41.15% decrease, with the full-year FY2023 number at $18.8 million, changed N/A from a year prior.
  • Preferred Dividend Payments hit $18.4 million in Q4 2023 for CG Oncology, up from $5.3 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $18.4 million in Q4 2023 to a low of $3.7 million in Q1 2023.